2m 2m 2m 2m 2m 2m 2m
Atricure (ATRC)
NASDAQ
$59.41+$1.74 (+3.02%)
Price as of Oct 22, 2026 7:30 PM EDT- $2.9BMarket Cap
- 55.40%1-Year Change
- Medical Instruments & SuppliesIndustry
Atricure (ATRC)
$59.41+$1.74 (+3.02%)
ATRC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $57.67 | ||
Change | $0.00 (0.00%) | ||
Open | $57.73 | ||
High | $59.29 | ||
Low | $57.13 | ||
Previous Close | $57.67 | ||
Volume | 566,328 | ||
30-Day Average Volume | 953,565 | ||
1-Week Change | 0.65% | ||
1-Month Change | -1.11% | ||
1-Year Change | 55.40% | ||
3-Year Change | 62.18% | ||
5-Year Change | -20.25% | ||
Fundamentals | |||
Shares Outstanding | 50.9M | ||
Total Assets | $676.6M | ||
Market Cap | $2.9B | ||
Enterprise Value | $2.9B | ||
Period: QTR TTM FY | |||
Revenue | $153.6M | ||
Net Income | $9.0M | ||
Free Cash Flow | $18.4M | ||
EBIT | $9.4M | ||
EBITDA | $11.8M | ||
Net Working Capital | $263.6M | ||
EPS | $0.18 | ||
Enterprise Value/EBITDA | 245 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 6 | ||
P/E | 320 | ||
PEG | N/A | ||
Price/Free Cash Flow | 159 | ||
Price/Operating Cash Flow | 132 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue